Lufuradom

Lufuradom (INN) is a drug and benzodiazepine derivative which, unlike other benzodiazepines, is described as an analgesic.[1] Similarly to its analogue tifluadom, it was never marketed.

Lufuradom
Clinical data
ATC code
  • None
Identifiers
IUPAC name
  • N-[(8-fluoro-1-methyl-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-yl)methyl]-3-furamide
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC22H20FN3O2
Molar mass377.419 g·mol−1
3D model (JSmol)
SMILES
  • O=C(C1=COC=C1)NCC2N(C)C3=C(C(C4=CC=CC=C4)=NC2)C=CC(F)=C3
InChI
  • InChI=1S/C22H20FN3O2/c1-26-18(13-25-22(27)16-9-10-28-14-16)12-24-21(15-5-3-2-4-6-15)19-8-7-17(23)11-20(19)26/h2-11,14,18H,12-13H2,1H3,(H,25,27)
  • Key:QJSCDZOUCFWCKD-UHFFFAOYSA-N

See also
  • Tifluadom
  • GYKI-52895, structural benzodiazepine which is a dopamine reuptake inhibitor without GABAergic function
  • GYKI-52,466, structural benzodiazepine which is an AMPAkine and glutamate antagonist without GABAergic function

References
  1. World Health Organization (31 December 1988). International nonproprietary names (INN) for pharmaceutical substances, 1988: lists 1-58 of proposed INN and lists 1-27 of recommended INN : cumulative list. World Health Organization. p. 252. ISBN 978-92-4-056014-7. Retrieved 26 April 2012.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.